Complete your view of COVID-19 with T cell testing.


Serology alone is not enough1 The T-SPOT.COVID test:


•Detects T cell response to SARS-CoV-2 •CE marked and submitted to the FDA for EUA •Modified ELISPOT test using the proven T-SPOT technology platform


In a clinical study on US subjects, the T-SPOT.COVID test identified 51% more PCR positive individuals than serology testing alone.


For more information visit: www.tspotcovid.com


References: The T-SPOT.COVID package insert - T-SPOT.COVID-PI-UK-0001 V3


T-SPOT is a registered trademark of Oxford Immunotec Ltd


The Oxford Immunotec logo is a registered trademark of Oxford Immunotec Ltd © 2021 Oxford Immunotec. All rights reserved P435-UK-AD-MPN537-0001 V1


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59